Menu
The spatial biology company with proven clinical value
HAWK Biosystems was founded by leading scientists of Parker’s Laboratory at Cancer Research UK/Francis Crick Institute. Initially known as FASTBASE Solutions, our journey began in 2016 and since our creation, we have had a goal of creating high-quality technologies for the quantification of protein and biomarker function within patient tissue samples. By promoting scientific excellence and taking the approach to assess protein function, rather than expression, we have been able to accelerate translational biomarker research and identify functional biomarkers with clinical value. Ultimately, our goal is that these technologies better the lives of patients and researchers worldwide.
Francis Crick Institute
Moving forward to 2022, we now have a talented and motivated international team who are constantly driving our company to newer heights. We started the design of our Violet 3.0 benchtop microscopy solution, aimed to allow QF-Pro® to be accessible in house to any research lab in the life science sector, removing the perception that FRET-FLIM based technologies were only suited to physics and imaging laboratories. Meanwhile, we embarked on a study to showcase the power of QF-Pro® and how it could benefit cancer patients, by demonstrating the power of functional proteomics in the field of immuno-oncology. In a study, published in the Journal of Clinical Oncology, we demonstrated that the ability of QF-Pro® to quantify PD-1/PD-L1 interaction states in the biopsies of lung cancer patients. This proved to be a metric which could accurately predict response to anti-PD-1/PD-L1 immune checkpoint inhibitor therapies, far more robustly than the current clinical gold-standard biomarker, PD-L1 TPS score. The results were ground-breaking, QF-Pro® could triple response rates to these therapies and double overall survival rates in lung cancer alone.
In the summer of 2022, we changed our commercial brand name to HAWK Biosystems, a move to reflect our changing direction as a provider of breakthrough technologies able to spatially quantify proteomic events at an unrivalled precision. We continue to apply and work to achieve CE marking and EMA/FDA approval for the use of QF-Pro® in the clinical immuno-oncology domain where it can benefit hundreds of thousands of patients each year.
Our Guiding Principles: Explore Our Core Values!
We promote a culture of transparency and trust.
We take pride in the people who are part of our success.
We thrive on providing unique innovative technologies
We strive to find solutions to any problem and do not give up.
Our aim is to use our technology to elucidate and quantify breakthrough biomarkers in pathology. Unlike competing technologies, our combined spectroscopy and imaging offers sub-pixel resolution and precision unobtainable with competing techniques. Our novel technology allows us to reveal cellular signalling events which are otherwise missed and may prove key to discovering new therapies and correctly guiding patient treatment decisions. We truly believe our technology can improve patient survival rates and quality of life in a wide range of different pathologies. We strive to become a company known for having revolutionised personalised medicines across the world.
“Upon completing my degrees in Biochemistry and Molecular Biology, followed by a master’s in Research, Development, Control, and Innovation of Medicines, I eagerly embarked on my professional journey at HAWK Biosystems. It’s been an incredible privilege to join this pioneering team as a junior scientist, contributing to the revolutionary work in biomarker discovery and quantification using our cutting-edge technology, QF-Pro®. I’m deeply grateful for the opportunity to be a part of such impactful research and for the support and mentorship I’ve received along the way.”
Markel Rementeria – Junior Scientist
Careers
Are you interested in joining our diverse and successful team? If so, head over to our careers page to see our current job vacancies. If none of our positions are suited to you, don’t worry, just send us your CV and we will contact you for suitable positions.
Meet the Team
Get to know everyone in our multinational team and learn the background and extensive experience of all our members, from our employees to our board of directors and scientific advisory board; all of whom make Hawk Biosystems a success.
This project has been co-funded by the European Union’s Horizon Europe research and innovation programme under grant agreement Nº101161495.
“Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.”
Stay connected
Subscribe to the HAWK Biosystems newsletter and don’t miss any news about our company, our products, events and much more.